Titre:
  • Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Auteur:Mauriac, Louis; Keshaviah, A; Debled, M; Mouridsen, Henning; Forbes, John F; Thürlimann, Beat; Paridaens, R.; Monnier, A; Láng, I; Wardley, Andrew; Nogaret, Jean-Marie; Gelber, R D; Castiglione-Gertsch, Monica; Price, K; Coates, Alan; Smith, Ian; Viale, Giuseppe; Rabaglio, M; Zabaznyi, N; Goldhirsch, Aron; BIG 1-98 Collaborative Group, ; International Breast Cancer Study Group,
Informations sur la publication:Annals of oncology, 18, 5, page (859-867)
Statut de publication:Publié, 2007-05
Sujet CREF:Cancérologie
MeSH keywords:Antineoplastic Agents, Hormonal -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Aromatase Inhibitors -- administration & dosage
Breast Neoplasms -- drug therapy -- pathology
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Follow-Up Studies
Humans
Middle Aged
Neoplasm Recurrence, Local -- drug therapy -- pathology
Neoplasms, Hormone-Dependent -- drug therapy
Nitriles -- administration & dosage
Postmenopause
Prognosis
Tamoxifen -- administration & dosage
Time Factors
Treatment Outcome
Triazoles -- administration & dosage
Note générale:Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdm001
info:pii/mdm001
info:scp/34249292099
info:pmid/17301074